ATC code V08

ATC codes
V Various
V01 Allergens
V03 All other therapeutic products
V04 Diagnostic agents
V06 General nutrients
V07 All other non-therapeutic products
V08 Contrast media
V09 Diagnostic radiopharmaceuticals
V10 Therapeutic radiopharmaceuticals
V20 Surgical dressings

A • B • C • D • G • H • QI • J • L • M • N • P • R • S • V

ATC code V08 Contrast media is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup V08 is part of the anatomical group V Various.[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QV08...[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

Contents

V08A X-ray contrast media, iodinated

V08AA Water-soluble, nephrotropic, high osmolar X-ray contrast media

V08AA01 Diatrizoic acid
V08AA02 Metrizoic acid
V08AA03 Iodamide
V08AA04 Iotalamic acid
V08AA05 Ioxitalamic acid
V08AA06 Ioglicic acid
V08AA07 Acetrizoic acid
V08AA08 Iocarmic acid
V08AA09 Methiodal
V08AA10 Diodone

V08AB Water-soluble, nephrotropic, low osmolar X-ray contrast media

V08AB01 Metrizamide
V08AB02 Iohexol
V08AB03 Ioxaglic acid
V08AB04 Iopamidol
V08AB05 Iopromide
V08AB06 Iotrolan
V08AB07 Ioversol
V08AB08 Iopentol
V08AB09 Iodixanol
V08AB10 Iomeprol
V08AB11 Iobitridol
V08AB12 Ioxilan

V08AC Water-soluble, hepatotropic X-ray contrast media

V08AC01 Iodoxamic acid
V08AC02 Iotroxic acid
V08AC03 Ioglycamic acid
V08AC04 Adipiodone
V08AC05 Iobenzamic acid
V08AC06 Iopanoic acid
V08AC07 Iocetamic acid
V08AC08 Sodium iopodate
V08AC09 Tyropanoic acid
V08AC10 Calcium iopodate

V08AD Non-watersoluble X-ray contrast media

V08AD01 Ethyl esters of iodised fatty acids
V08AD02 Iopydol
V08AD03 Propyliodone
V08AD04 Iofendylate

V08B X-ray contrast media, non-iodinated

V08BA Barium sulfate containing X-ray contrast media

V08BA01 Barium sulfate with suspending agents
V08BA02 Barium sulfate without suspending agents

V08C Magnetic resonance imaging contrast media

V08CA Paramagnetic contrast media

V08CA01 Gadopentetic acid
V08CA02 Gadoteric acid
V08CA03 Gadodiamide
V08CA04 Gadoteridol
V08CA05 Mangafodipir
V08CA06 Gadoversetamide
V08CA07 Ferric ammonium citrate
V08CA08 Gadobenic acid
V08CA09 Gadobutrol
V08CA10 Gadoxetic acid
V08CA11 Gadofosveset

V08CB Superparamagnetic contrast media

V08CB01 Ferumoxsil
V08CB02 Ferristene
V08CB03 Iron oxide, nanoparticles

V08CX Other magnetic resonance imaging contrast media

V08CX01 Perflubron

V08D Ultrasound contrast media

V08DA Ultrasound contrast media

V08DA01 Microspheres of human albumin
V08DA02 Microparticles of galactose
V08DA03 Perflenapent
V08DA04 Microspheres of phospholipids
V08DA05 Sulfur hexafluoride

References

  1. ^ "ATC/DDD Index 2012". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/. 
  2. ^ "ATCvet Index 2011". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/. 
X-ray and CT
Iodinated,
Water soluble
Nephrotropic,
high osmolar
Nephrotropic,
low osmolar
Hepatotropic
Iodinated,
Water insoluble
Non-iodinated
MRI
Ferumoxsil • Ferristene • Iron oxide, nanoparticles
Other
Ultrasound